67th ASH Annual Meeting Abstract Submission is Now Open – Inspire the Future of Hematology
The American Society of Hematology (ASH) shared an encouraging post on X:
”What you submit today could shape care tomorrow! Abstract submissions are open for ASH25. Share your findings with thousands of hematology pros this December. Every discovery counts! Deadline: August 5, 2025.”
The American Society of Hematology invites researchers and clinicians to submit abstracts for the 67th ASH Annual Meeting, taking place in December 2025.
This premier event gathers thousands of hematology professionals from around the world to exchange cutting-edge science and clinical advancements.
With the theme of innovation and impact, the meeting offers a platform for contributors at every stage of their careers to present their latest findings.
Whether your work focuses on basic science, translational research, or clinical practice, your submission has the potential to influence care and spark global collaboration.
Abstract submission deadline: August 5, 2025.
Be part of the future of hematology—because every discovery counts!
Submit your article now.
Latest news and updates on global conferences in hematology featured in Hemostasis Today.
-
Oct 27, 2025, 05:47Ahmed Koriesh on The Novel Approach in Use of Tenecteplase
-
Oct 27, 2025, 04:42Louise Breslin: Exciting Results in The CRYPTICS Trial
-
Oct 26, 2025, 16:55ECTH 2025: 3 Unforgettable Days of Science and Shared Purpose
-
Oct 26, 2025, 16:35Ahmed Koriesh on Thrombolysis in Stroke Patients on DOACs
-
Oct 26, 2025, 15:39Lisa Murphy on Life After Stroke Sessions at WSC 2025
-
Oct 27, 2025, 08:01Acquired Hemophilia A (AHA) is Rare and Often Missed - RPTH Journal
-
Oct 27, 2025, 05:00Wolfgang Miesbach on WFH Guidelines Covering FDA/EMA-Approved AAV Gene Therapy for Hemophilia
-
Oct 26, 2025, 15:04Nita Radhakrishnan and Colleagues on Inherited Haematological Conditions
-
Oct 26, 2025, 14:55Anirban Sen Gupta on Biosynthetic Blood Surrogates Current State-of-Art
-
Oct 26, 2025, 12:24Jean Philippe Galanaud, Jean Pierre Laroch, and Marc Righini on Historical Treatments of DVT
-
Oct 25, 2025, 07:42Adithya Hande: India’s Silent Killer and a Scientific Breakthrough
-
Oct 23, 2025, 09:57Arun V. J: Artificial Blood Is Closer Than You Think
-
Oct 23, 2025, 07:11Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
-
Oct 23, 2025, 07:05Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 27, 2025, 08:00Rohit Gosain: Revumenib is Now FDA Approved for R/R AML with NPM1 Mutation
-
Oct 27, 2025, 06:30Andres Ricaurte Fajardo on CVT Experience from a Latin American Cohort
-
Oct 27, 2025, 05:15Love Preet Kalra: I Had The Pleasure of Meeting Future Leader Sarah Matuja
-
Oct 25, 2025, 09:32Sylaja Pn Wins 2025 WSO Presidential Award
-
Oct 25, 2025, 08:21Courtney Lawrence: Listen. Empower. Deliver. Save Lives!